Related Experiment Videos
Molecular aspects of fibrinolysis
Annals of the New York Academy of Sciences
|January 1, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis.
Nanomedicine (London, England)·2007
A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen.
Thrombosis and haemostasis·2002
Temperature dependence of ultrasonic enhancement with a site-targeted contrast agent.
The Journal of the Acoustical Society of America·2001
Engineering Antivenom: Research Progress and Future Directions in Snakebite Envenoming Therapy.
Annals of the New York Academy of Sciences·2026
Loneliness Biases Social Engagement Decisions: Evidence From Value-Based Choice Models.
Annals of the New York Academy of Sciences·2026
Urban Climate Risk Governance and Corporate Energy Intensity: Evidence From China's Climate Adaptation City Pilots.
Annals of the New York Academy of Sciences·2026
Genetic Adaptation Accompanying the Emergence of Inkoo Virus, the European Orthobunyavirus jamestownense.
Annals of the New York Academy of Sciences·2026
Neurotechnological Natives and the Neurotechnology Shift: A Research Agenda for the Brain-as-Interface Era.
Annals of the New York Academy of Sciences·2026
Baseline Fatty Acids and Time-Averaged Executive Function in Ugandan Children With Perinatal HIV.
Annals of the New York Academy of Sciences·2026
Can Telehealth Improve Access to Amyloid-Targeting Therapies for Veterans Living With Alzheimer Disease?
Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
A Nomogram Integrating Clinical and Cardiac Imaging for Predicting Short-Term Left Ventricular Ejection Fraction Decline in Patients with Duchenne Muscular Dystrophy.
International journal of general medicine·2026
OAF Blocks SIAH1-Mediated Degradation of SCPX, a Therapeutic Strategy for MASLD.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Real World Data and Its Impact on the Management of Plasma Cell Dyscrasias.
Current hematologic malignancy reports·2026